Alzamend Neuro (ALZN) Short Interest Ratio & Short Volume → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free ALZN Stock Alerts $0.68 -0.02 (-2.88%) (As of 04/19/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Alzamend Neuro Short Interest DataCurrent Short Volume45,300 sharesPrevious Short Volume51,200 sharesChange Vs. Previous Month-11.52%Dollar Volume Sold Short$45,300.00Short Interest Ratio / Days to Cover0.8Last Record DateMarch 31, 2024Outstanding Shares6,870,000 sharesFloat Size4,830,000 sharesShort Percent of Float0.94%Today's Trading Volume27,986 sharesAverage Trading Volume53,461 sharesToday's Volume Vs. Average52% Short Selling Alzamend Neuro ? Sign up to receive the latest short interest report for Alzamend Neuro and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatALZN Short Interest Over TimeALZN Days to Cover Over TimeALZN Percentage of Float Shorted Over Time Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> Alzamend Neuro Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202445,300 shares $45,300.00 -11.5%0.9%0.8 $1.00 3/15/202451,200 shares $47,616.00 +13.0%1.0%0.9 $0.93 2/29/202445,300 shares $40,770.00 +2.5%0.9%0.7 $0.90 2/15/202444,200 shares $39,019.76 +4.5%0.9%0.8 $0.88 1/31/202442,300 shares $36,378.00 -41.5%0.9%0.3 $0.86 1/15/202472,300 shares $70,449.12 -2.8%1.9%0.5 $0.97 Get the Latest News and Ratings for ALZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. 12/31/202374,400 shares $66,216.00 -43.5%2.1%0.6 $0.89 12/15/2023131,700 shares $131,700.00 -29.5%3.7%1 $1.00 11/30/2023186,900 shares $226,149.00 +379.2%5.7%1.6 $1.21 11/15/202339,000 shares $58,500.00 -18.2%1.2%0.4 $1.50 10/31/202347,700 shares $1.25 million -92.1%1.5%2.3 $26.26 10/15/2023602,000 shares $124,012.00 +30.0%1.2%2.8 $0.21 9/30/2023463,200 shares $109,778.40 +82.8%1.0%2.2 $0.24 9/15/2023253,400 shares $60,816.00 +17.3%0.5%1.3 $0.24 8/31/2023216,000 shares $56,635.20 -60.7%0.4%1.2 $0.26 8/15/2023549,900 shares $169,919.10 +8.9%1.2%2.8 $0.31 7/31/2023505,200 shares $228,855.60 +2.6%1.1%3 $0.45 7/15/2023492,500 shares $247,235.00 +4.0%1.1%3.1 $0.50 6/30/2023473,700 shares $241,587.00 +13.0%1.1%2.9 $0.51 6/15/2023419,400 shares $285,192.00 -44.9%0.9%2.5 $0.68 5/31/2023761,400 shares $552,928.68 +44.0%1.7%4.2 $0.73 5/15/2023528,600 shares $274,713.42 -11.1%1.2%3.2 $0.52 4/30/2023594,400 shares $325,315.12 -8.6%1.3%3.5 $0.55 4/15/2023650,500 shares $382,038.65 +10.9%1.4%3.4 $0.59 3/31/2023586,500 shares $249,262.50 -18.2%1.3%2.9 $0.43 3/15/2023717,000 shares $343,729.80 -0.4%1.6%2.4 $0.48 2/28/2023719,600 shares $386,353.24 +5.1%1.6%2.4 $0.54 2/15/2023685,000 shares $401,478.50 -31.1%1.5%2.2 $0.59 1/31/2023994,100 shares $659,784.17 +11.2%2.2%2.8 $0.66 1/15/2023893,700 shares $529,964.10 -44.8%2.0%2.5 $0.59 12/30/20221,620,000 shares $915,138.00 +3.2%4.5%4.4 $0.56 12/15/20221,570,000 shares $1.40 million -7.7%4.4%3.6 $0.89 11/30/20221,700,000 shares $1.96 million -20.6%5.8%3.3 $1.15 11/15/20222,140,000 shares $2.40 million +27.4%7.3%4 $1.12 10/31/20221,680,000 shares $1.97 million -11.1%5.4%2.9 $1.17 10/15/20221,890,000 shares $1.98 million -34.2%5.5%3.1 $1.05 9/30/20222,870,000 shares $3.42 million +221.9%8.4%4.8 $1.19 9/15/2022891,700 shares $1.11 million -33.0%2.6%1.9 $1.24 8/31/20221,330,000 shares $1.20 million +112.9%3.9%3.7 $0.91 8/15/2022624,800 shares $649,792.00 -40.5%1.8%1.6 $1.04The “Perfect Storm” for Gold (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! ALZN Short Interest - Frequently Asked Questions What is Alzamend Neuro's current short interest? Short interest is the volume of Alzamend Neuro shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 45,300 shares of ALZN short. 0.94% of Alzamend Neuro's shares are currently sold short. Learn More on Alzamend Neuro's current short interest. What is a good short interest ratio for Alzamend Neuro? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALZN shares currently have a short interest ratio of 1.0. Learn More on Alzamend Neuro's short interest ratio. Which institutional investors are shorting Alzamend Neuro? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Alzamend Neuro: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Alzamend Neuro? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.94% of Alzamend Neuro's floating shares are currently sold short. Is Alzamend Neuro's short interest increasing or decreasing? Alzamend Neuro saw a drop in short interest in March. As of March 31st, there was short interest totaling 45,300 shares, a drop of 11.5% from the previous total of 51,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Alzamend Neuro's float size? Alzamend Neuro currently has issued a total of 6,870,000 shares. Some of Alzamend Neuro's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Alzamend Neuro currently has a public float of 4,830,000 shares. How does Alzamend Neuro's short interest compare to its competitors? 0.94% of Alzamend Neuro's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Alzamend Neuro: Exicure, Inc. (2.40%), Seelos Therapeutics, Inc. (5.82%), Kineta, Inc. (0.82%), Oragenics, Inc. (2.07%), Sonnet BioTherapeutics Holdings, Inc. (16.27%), GT Biopharma, Inc. (0.71%), LumiraDx Limited (2.89%), Synaptogenix, Inc. (1.09%), Bright Minds Biosciences Inc. (2.58%), Soligenix, Inc. (1.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Alzamend Neuro stock? Short selling ALZN is an investing strategy that aims to generate trading profit from Alzamend Neuro as its price is falling. ALZN shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Alzamend Neuro? A short squeeze for Alzamend Neuro occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALZN, which in turn drives the price of the stock up even further. How often is Alzamend Neuro's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALZN, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Exicure Short Interest Data Seelos Therapeutics Short Interest Data Kineta Short Interest Data Oragenics Short Interest Data Sonnet BioTherapeutics Short Interest Data GT Biopharma Short Interest Data LumiraDx Short Interest Data Synaptogenix Short Interest Data Bright Minds Biosciences Short Interest Data Soligenix Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALZN) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy Sykes